RankAlpha logo
Back to Rankings

SERA

Sera PrognosticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
SERA vs peer average
40/100
SERA vs. peer average (F vs. D)
Grade spread
C 2 · D 1 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

ATHE is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $83.27M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerATHEAlteriry Therapeutics
SERA
Sera Prognostics
ATHE
Alteriry Therapeutics
Grade
F
F
Momentum
28
13
Value
41
41
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs ATHE

SERA / ATHE
Grade Position
Below peers
SERA vs. peer average (F vs. D)
40/100
Momentum
28
SERA
Value
41
SERA
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs SERA
1
ATHE
Alteriry Therapeutics Ltd ADR
F
20/100
Even
2
SPRO
Spero Therapeutics Inc Common
F
20/100
Even
3
FRMM
Forum Markets Inc Common
F
20/100
Even
4
CSBR
Champions Oncology Inc Common
C
60/100
-2
5
NTHI
NeOnc Technologies Holdings Inc Common
F
20/100
Even
ATHE is the first peer returned for this comparison set.